Of 1143 participants with type 2 diabetes, 258 were excluded due to incomplete data on clustering variables, seven due to fasting plasma glucose and C-peptide values outside the acceptable range for HOMA calculation and 19 due to GAD antibodies. The gene discussed is GAD1; the disease is type 2 diabetes mellitus.